Genocea Biosciences Inc (GNCA.OQ)
18 May 2018
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|49||2013||Chairman of the Board|
|55||2011||President, Chief Executive Officer, Director|
|54||2016||Executive Vice President - Pharmaceutical Sciences|
|2018||Senior Vice President - Pharmaceutical Sciences and Manufacturing|
|44||2016||Chief Scientific Officer|
- BRIEF-Genocea Biosciences Files For Mixed Shelf Of Up To $200 Mln
- BRIEF-Genocea Biosciences Files For Non-Timely 10-Q - SEC Filing
- BRIEF-Genocea Reports Qtrly Loss Per Share $0.21
- BRIEF-Genocea Biosciences Enters Into Term Loan Facility Of $14 Million With Hercules
- BRIEF-Genocea Files IND For Neoantigen Cancer Vaccine Candidate Gen-009